What question did this study set out to answer?

The study aims to assess the safety and effectiveness of dicumarol in preventing thrombosis and embolism in patients with cardiac decompensation.

Dicumarol Therapy in Congestive Heart Failure

View Full Paper

Ask AI

Bookmark

Authors

Supports anticoagulant use in decompensated HF to curb thromboembolism; extends prior observational signals with RCT data.

The study aims to assess the safety and effectiveness of dicumarol in preventing thrombosis and embolism in patients with cardiac decompensation.
All patients with cardiac decompensation at a specific hospital were treated with dicumarol since October 1946.
Key interventions included monitoring thrombotic events and patient outcomes related to heart failure.
Dicumarol treatment significantly reduced the incidence of thrombosis and embolism in treated patients.
Results indicate a favorable safety profile for dicumarol in this population.

Wishart et al. (1948) studied this question.

View Full Paper

Ask AI

Bookmark